MoneyWorks4Me

Granules India informs about presentation to analysts

11 May 2021 Evaluate

With reference to audited financial results for the fourth quarter and year ended March 31, 2021 submitted today, Granules India has informed that it has enclosed the presentation in this regard to the Analysts/ Investors which is also being uploaded on the website. This is pursuant to Regulation 46 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1758.30
Dr. Reddys Labs. 1179.20
Cipla 1299.20
Lupin 1950.30
Zydus Lifesciences 1110.15
View more..